✦ LIBER ✦

Cyclophosphamide, epirubicin and fluorouracil controls metastatic breast tumors more effectively than cyclophosphamide, methotrexate, and fluorouracil

✍ Scribed by Olivia Pagani

Book ID: 114483802
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 192 KB
Volume: 2
Category: Article
ISSN: 1363-4054
DOI: 10.1054/ebon.2001.0146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of cyclophosphamide, ep

Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

✍ Morihiko Kimura; Takeshi Tominaga; Yuichi Takatsuka; Masakazu Toi; Rikiya Abe; H 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 224 KB

Epirubicin and Cyclophosphamide, Methotr

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

✍ Denlinger, C.S.; Goldstein, L.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Combination chemotherapy for metastatic

Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate

✍ Ambrose Aboud; Aman U. Buzdar; Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. B 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r

Low dose chemotherapy of metastatic brea

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin

✍ Richard H. Creech; Robert B. Catalano; David T. Harris; Paul F. Engstrom; Paul J 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Accelerated versus standard cyclophospha

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

✍ Baldini, E. 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 110 KB

An effective low-dose intermittent cyclo

An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer

✍ Richard H. Creech; Robert B. Catalano; Michael J. Mastrangelo; Paul F. Engstrom 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

A low-dose, three-drug regimen, C.M.F. (cyclophosphamide 50 mg, P.o., days 1-14; methotrexate, 25 mg, and 5-fluorouracil, 500 mg, i.v., days 1 and 8; cycled every 28 days) was used in 46 consecutive chemotherapy-eligible women (41 previously hormonally treated) with recurrent breast cancer. Thirteen